51 filings
8-K
Prolung Inc
1 Sep 23
Other Events
1:33pm
8-K
Prolung Inc
28 Jun 22
Submission of Matters to a Vote of Security Holders
1:24pm
8-K
Prolung Inc
8 Mar 22
IONIQ Sciences Announces Acquisition of Intellectual Property and Buyout of License
5:09pm
8-K
Prolung Inc
3 Feb 22
IONIQ Sciences Announces Submission of De Novo Application to FDA
12:00am
8-K
Prolung Inc
7 Oct 21
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors
6:10am
8-K
bk7bwlvz8 4bxpwp
14 Jul 21
Submission of Matters to a Vote of Security Holders
12:40pm
8-K
d8b31xohnt0xb01p927o
28 May 21
Unregistered Sales of Equity Securities
5:27pm
8-K
0ux0oof679aqt33ol7
28 May 20
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
6:05am
8-K
xbqzay0wcp 69lowcse
22 May 20
Unregistered Sales of Equity Securities
5:23pm
8-K
r5nygb kyg9
10 Mar 20
Changes in Registrant's Certifying Accountant
5:08pm
8-K
15xcvk2w0e
27 Feb 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
er14 re1jns
13 Feb 20
ProLung Test™ Granted ‘Breakthrough Device’ Designation by the FDA
5:19pm
8-K
s4x0fk zzqr
13 Feb 20
Regulation FD Disclosure
12:00am
8-K
822x3y
27 Nov 19
Other Events
11:04am
8-K
dkes2hwwatb75s3u
26 Nov 19
ProLung Announces Change to its Board of Directors
3:27pm
8-K
gizt2y x4xpqyxc9
3 Oct 19
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
4:00pm
8-K
1sbxlgp6
12 Aug 19
ProLung Announces the Appointment of Leavitt Partners and Mr. Rich
3:00pm
8-K
31n1n5g ht09ds9
2 Aug 19
Unregistered Sales of Equity Securities
2:42pm
8-K
k5lrkz1lvgd4lefnd5x1
12 Jun 19
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise
4:21pm
8-K
w4c8 y9dw1uj
11 Dec 18
Submission of Matters to a Vote of Security Holders
5:27pm